A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years
Clinical trial NCT03962062 · COMPLETED
Trial details
- NCT number
- NCT03962062
- Sponsor
- Medicines Development for Global Health
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2022-05-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.